Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects.
about
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationOpioid metabolismEvaluation of CYP2D6 oxidation of dextromethorphan and propafenone in a Chinese population with atrial fibrillation.Genetic basis for a lower prevalence of deficient CYP2D6 oxidative drug metabolism phenotypes in black Americans.Pharmacogenetics and psychopharmacotherapy.Ethnic differences in nifedipine kinetics: comparisons between Nigerians, Caucasians and South Asians.Pharmacokinetics in the child.CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population.Pharmacogenomics and functional gastrointestinal disorders.Depressive symptoms and SSRI use in pediatric oncology patients.Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.Ethnicity and psychopharmacology.Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.Genetic polymorphism in cytochrome P450 2D6 (CYP2D6): Population distribution of CYP2D6 activity.Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations.CYP2D6 Genetic Polymorphisms and Phenotypes in Different Ethnicities of Malaysian Breast Cancer Patients.Genetic differences in drug disposition.Ethnicity and antipsychotic response.Genetic polymorphism of CYP2D6 in a keralite (South India) population.Sparteine metabolism in a Nigerian population.Pharmacogenetics: part II: Perspective. 1992.Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science.
P2860
Q24681317-0AA59F05-D06F-46B3-A9A3-A62E08BE1DCAQ28250437-172BBEB4-8F4C-47F6-97B7-182EDE296201Q31806016-097A853A-5D0A-457C-AEE7-333DCEA4EB21Q33899650-B0558982-9A05-4EA2-8C38-52EFA0B2B27EQ33962212-E2587359-5FD4-4FC7-A0E2-BD3488214C7CQ34347670-D8F569F9-9990-49E1-9935-BCA9DD85AFB3Q35030779-197B100D-CC76-40D0-8224-399650F33F41Q36053309-755AF92B-65F0-41F6-930F-3D70DDA0ADE5Q36053715-493B0068-32FB-4722-9BD4-826C0128F7FDQ36192802-73385AEC-2450-4F1E-97BB-EC2448400DAAQ36793080-B9FA13DA-6F78-44F8-A8FE-4DF23B861EE6Q37047429-6A135E65-E1C2-4022-9684-7D6AC930ECC0Q37097622-5F6B1A80-1FB5-4964-811A-BBD68D43CA8FQ37122997-D6BA9E08-AC05-416A-BDA1-CE52DE0ADCB9Q37611786-312AE87D-91FA-4917-B5DE-F50CE505D3BCQ37698407-AD6B5CD1-041D-471B-8ABD-27027D1D2EF9Q38133628-E7778A76-DA58-41D4-A020-D0C8B3E2670EQ38260323-977575AE-4BA7-468E-AFC9-99626F51BAAAQ40382805-B5CFF072-8340-427C-82C5-AAEAE920FF06Q40645305-967EEDFE-17CF-4056-90E0-6C70633D79F7Q40876700-9C2E98E1-4CD1-4F10-A1C3-66EAC130904EQ42561477-879DC85F-9811-4083-8F9F-DB8AB8DA7964Q46855296-4BF863B2-9B02-472A-9B4B-A78239D31DB7Q48543727-8893A0DE-2E81-4A5C-814E-AB16D512C669Q50707361-B0229FD1-22B8-4D0E-A75A-FF400236FA97
P2860
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects.
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Lower prevalence of the debris ...... n black versus white subjects.
@ast
Lower prevalence of the debris ...... n black versus white subjects.
@en
Lower prevalence of the debris ...... n black versus white subjects.
@nl
type
label
Lower prevalence of the debris ...... n black versus white subjects.
@ast
Lower prevalence of the debris ...... n black versus white subjects.
@en
Lower prevalence of the debris ...... n black versus white subjects.
@nl
prefLabel
Lower prevalence of the debris ...... n black versus white subjects.
@ast
Lower prevalence of the debris ...... n black versus white subjects.
@en
Lower prevalence of the debris ...... n black versus white subjects.
@nl
P2093
P356
P1476
Lower prevalence of the debris ...... n black versus white subjects.
@en
P2093
P304
P356
10.1038/CLPT.1991.141
P407
P577
1991-09-01T00:00:00Z